Pharvaris N.V.
PHVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $98,564 | $65,575 | $57,376 | $35,789 |
| G&A Expenses | $46,725 | $31,339 | $29,039 | $18,349 |
| SG&A Expenses | $47,125 | $31,339 | $29,339 | $18,349 |
| Sales & Mktg Exp. | $400 | $0 | $300 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $145,688 | $96,914 | $86,715 | $54,139 |
| Operating Income | -$145,688 | -$96,914 | -$86,715 | -$54,139 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $13,292 | -$2,913 | $11,061 | $11,478 |
| Pre-Tax Income | -$132,396 | -$99,826 | -$75,653 | -$42,661 |
| Tax Expense | $1,825 | $1,049 | $679 | $70 |
| Net Income | -$134,221 | -$100,875 | -$76,333 | -$42,731 |
| % Margin | – | – | – | – |
| EPS | -2.48 | -2.63 | -2.27 | -1.41 |
| % Growth | 5.7% | -15.9% | -61% | – |
| EPS Diluted | -2.48 | -2.63 | -2.27 | -1.41 |
| Weighted Avg Shares Out | 54,020 | 38,391 | 33,586 | 30,412 |
| Weighted Avg Shares Out Dil | 54,021 | 38,392 | 33,586 | 30,412 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,469 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $16 | $278 |
| Depreciation & Amortization | $95 | $258 | $153 | $77 |
| EBITDA | -$145,593 | -$96,656 | -$86,562 | -$54,061 |
| % Margin | – | – | – | – |